Skip to main content

Advertisement

Table 1 Prevalence and incidence AHR Colombia 2010–2014

From: 7th drug hypersensitivity meeting: part one

  2010 % (n) 2011 % (n) 2012 % (n) 2013 % (n) 2014 % (n)
Prevalence AHR Colombia
Cases per million
 1–5 años 0.4 (1) 5.1 (17) 2.4 (9) 5.2 (17) 3.8 (13)
 6–9 años 5.4 (15) 6.9 (23) 4 (15) 5.2 (17) 3.2 (11)
 10–14 años 8 (22) 6.3 (21) 9.2 (35) 10.8 (35) 12.1 (42)
 15–18 años 8.3 (23) 6.9 (23) 7.4 (28) 7.7 (25) 10.8 (37)
 19–26 años 14.9 (41) 13.9 (46) 19.8 (75) 18.8 (61) 16.8 (58)
 27–44 años 34.8 (96) 32 (106) 29.8 (113) 26.2 (85) 27.7 (96)
 45–59 años 19.2 (53) 19 (63) 16.4 (62) 16.6 (54) 14.5 (50)
 >60 años 9.1 (25) 9.7 (32) 11.1 (42) 9.5 (31) 11.3 (39)
 Total 100 (276) 100 (331) 100 (379) 100 (325) 100 (346)
Incidence AHR Colombia
Cases per million
 1–5 años 0 (0) 0 (0) 0 (0) 2.5 (1) 8.2 (4)
 6–9 años 5.4 (3) 0 (0) 2.4 (1) 5 (2) 10.2 (5)
 10–14 años 8 (4) 9.3 (5) 9.5 (4) 2.5 (1) 10.2 (5)
 15–18 años 8.3 (2) 7.4 (4) 7.1 (3) 10 (4) 18.4 (9)
 19–26 años 14.9 (4) 20.4 (11) 21.4 (9) 22.5 (9) 20.4 (10)
 27–44 años 34.8 (10) 35.2 (19) 26.2 (11) 25 (10) 16.3 (8)
 45–59 años 19.2 (8) 18.5 (10) 23.8 (10) 22.5 (9) 8.2 (4)
 >60 años 9.1 (7) 9.3 (5) 9.5 (4) 10 (4) 8.2 (4)
 Total 100 (38) 100 (54) 100 (42) 100 (40) 100 (49)